Latest News

Noxopharm Releases Report on Key Progress of Subsidiary
Annual Report to shareholders
NOX Subsidiary Announces Important Drug Discovery
NOX to support expanded LuPIN study
Nyrada-Key progress with cholesterol-lowering drug candidate
VEYONDA - Registered Trade Mark for NOX66
Interim NOX66 Radiotherapy Clinical Data
Release of DARRT-1 Preliminary Safety Data
Pre-Clinical data confirms Radio-Enhancing potential
Noxopharm Corporate Presentation for Public Briefing